Virginia Mui

Virginia Mui is a seasoned professional in quality assurance and clinical research, currently serving as Senior Director of Quality Assurance at BridgeBio since March 2024. With a robust background that includes key roles at Ascendis Pharma as Director of GCP and GVP Quality, and at BioMarin Pharmaceutical Inc. as Associate Director of GCP Compliance Strategy, Virginia has amassed extensive experience in ensuring compliance and enhancing quality in clinical operations. Previous positions held at Exelixis, Amgen, Eli Lilly, Memorial Sloan-Kettering Cancer Center, and NYU Medical Center reflect a comprehensive career progression in clinical trial management and quality assurance. Virginia holds a Master of Public Health in Community Health Education from New York University and a Bachelor of Arts in Sociology from Stony Brook University.